SAN DIEGO--(BUSINESS WIRE)--Jan. 4, 2006--Illumina, Inc.(NASDAQ:ILMN) announced today that Jay Flatley, President and CEO,will present an overview of the Company's commercial and productdevelopment activity at the upcoming JP Morgan Healthcare Conferencein San Francisco, CA.
Mr. Flatley's presentation will be webcast live beginning on orabout 8:00 a.m. Pacific Time (PT) on Thursday, January 12, 2006. Thewebcast presentation may be accessed athttp://equityconferences.jpmorgan.com/where it will be archived for30 days following the presentation.
Illumina (www.illumina.com) is developing next-generation toolsthat permit large-scale analysis of genetic variation and function.The Company's proprietary BeadArray(TM) technology -- now used inleading genome centers around the world -- provides the throughput,cost effectiveness and flexibility to enable researchers in the lifesciences and pharmaceutical industries to perform the billions oftests necessary to extract medically valuable information fromadvances in genomics and proteomics. This information will help pavethe way to personalized medicine by correlating genetic variation andgene function with particular disease states, enhancing drugdiscovery, allowing diseases to be detected earlier and morespecifically, and permitting better choices of drugs for individualpatients.
CONTACT: Illumina, Inc.
Jay Flatley, 858-202-4501
jflatley@illumina.com
or
William Craumer, 858-202-4667
bcraumer@illumina.com
SOURCE: Illumina, Inc.